SCALETTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.515
EU - Europa 917
AS - Asia 224
AF - Africa 9
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.668
Nazione #
US - Stati Uniti d'America 1.509
RU - Federazione Russa 291
PL - Polonia 264
IT - Italia 114
IE - Irlanda 87
CN - Cina 77
SG - Singapore 69
SE - Svezia 58
HK - Hong Kong 49
GB - Regno Unito 32
FI - Finlandia 20
IN - India 17
DE - Germania 14
UA - Ucraina 14
BE - Belgio 12
CI - Costa d'Avorio 6
JO - Giordania 6
CA - Canada 5
ES - Italia 4
FR - Francia 4
EG - Egitto 3
VN - Vietnam 3
NL - Olanda 2
TR - Turchia 2
AU - Australia 1
CH - Svizzera 1
EU - Europa 1
KR - Corea 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 2.668
Città #
Santa Clara 276
Warsaw 264
Fairfield 203
Woodbridge 123
Chandler 113
Ashburn 88
Dublin 87
Ann Arbor 82
Seattle 77
Houston 72
Cambridge 61
Wilmington 61
Singapore 56
Florence 45
Beijing 41
Hong Kong 32
Lawrence 29
Princeton 28
Altamura 27
Buffalo 23
Jacksonville 18
Boston 17
Mumbai 14
Shanghai 14
Boardman 13
Brussels 12
Medford 10
Los Angeles 9
San Diego 9
Abidjan 6
Toronto 5
Barcelona 4
Bologna 4
Cagliari 4
Falls Church 4
London 4
New York 4
Shenzhen 4
Dong Ket 3
Fuzhou 3
Moscow 3
New Delhi 3
Norwalk 3
Andover 2
Bremen 2
Cairo 2
Dearborn 2
Istanbul 2
Romainville 2
Shenyang 2
Verona 2
West Jordan 2
Yubileyny 2
Auburn Hills 1
Auckland 1
Bochum 1
Campi Bisenzio 1
Cedar Knolls 1
Chieti 1
Fossalunga 1
Frankfurt Am Main 1
Genova 1
Guangzhou 1
Hangzhou 1
Hillsboro 1
Huzhou 1
Kent 1
Laurel 1
Modena 1
Monticiano 1
Nürnberg 1
Phoenix 1
Piacenza 1
Prato 1
Quartu Sant'elena 1
Redmond 1
Redwood City 1
Rotterdam 1
Rui'an 1
Scandicci 1
Serra 1
Tappahannock 1
Trumbull 1
Vicchio 1
Vigevano 1
Yiwu 1
Totale 2.011
Nome #
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 240
Engineering Gold Nanorods for Cancer Treatment: Biological Profile, Protein Interactions and Drug Delivery. 234
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 160
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 134
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 134
Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes 133
The mode of action of anticancer gold-based drugs: a structural perspective 119
{Ru(CO)x}-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells 117
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 115
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 107
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 103
Size dependent biological profiles of PEGylated gold nanorods 101
Ru(CO)x-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo 96
Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound 95
null 93
Tuning the interactions of PEG-coated gold nanorods with BSA and model proteins through insertion of amino or carboxylate groups 90
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 84
The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresis–inductively coupled plasma mass spectrometry 73
Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes 68
null 68
Rapid purification of gold nanorods for biomedical applications 66
Mechanistic studies on cytotoxic gold compounds 61
Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1 55
Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications 55
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme 53
null 31
null 21
Totale 2.706
Categoria #
all - tutte 7.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020353 0 0 0 0 51 50 49 58 50 32 50 13
2020/2021222 16 29 8 22 13 43 8 15 22 22 8 16
2021/2022170 3 15 13 6 5 6 8 13 6 13 33 49
2022/2023439 50 100 30 32 28 71 57 22 29 0 18 2
2023/2024139 8 17 25 4 8 14 5 39 3 6 2 8
2024/2025739 41 123 64 164 347 0 0 0 0 0 0 0
Totale 2.706